BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025

  April 4, 2025

   · 

  8 min read
• Press Releases

  Elutia to Participate in Upcoming April 2025 Investor Conferences

  April 4, 2025

   · 

  1 min read
• Press Releases

  Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa

  April 4, 2025

   · 

  3 min read
• Press Releases

  Greenwich LifeSciences Provides Global Update on FLAMINGO-01

  April 4, 2025

   · 

  16 min read
• Press Releases

  AlzeCure Pharma publishes its Annual Report for 2024

  April 4, 2025

   · 

  3 min read
• Press Releases

  UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE

  April 4, 2025

   · 

  20 min read
• Press Releases

  Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress

  April 4, 2025

   · 

  11 min read
• Press Releases

  Blackstone Life Sciences and Anthos Therapeutics Announce Novartis has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at up to $3.1B, with $925M Paid Upfront

  April 4, 2025

   · 

  4 min read
• Press Releases

  AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

  April 4, 2025

   · 

  1 min read
• Press Releases

  Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update

  April 4, 2025

   · 

  1 min read